# Bioliberty Ltd: Form D capital raise (Edinburgh, X0)

**Vendor Spend Propensity Score (CPA / Tax / Audit):** 56/100
**Estimated post-raise budget for this service type:** $6,718 (heuristic)

| Field | Value |
|---|---|
| Industry | Other Technology (Technology & SaaS) |
| Operating company | Yes |
| Exemption | 506(b) |
| Amount sold | $335,906 |
| Total offering | $660,905 |
| Investors so far | 2 |
| First sale | 2026-10-16 |
| Filed | 2026-10-26 |
| Entity | Other |

## Executives and related persons (as listed in the filing)
- Barry Hextall: Executive Officer
- Rowan Armstrong: Director
- Conan Bradley: Director
- Shea Quinn: Director
- Ross O'Hanlon: Director
- Ramy El-Madany: Director
- David O'Reilly: Director
- Russell Bailey: Director
- Dana Strauss: Director
- Albert Nicholl: Director

## Why this score
- Operating company: new capital typically funds hiring, facilities and vendors.
- Raised $335,906 so far: a smaller raise.
- Technology & SaaS companies are a strong fit for CPA / Tax / Audit services.
- New filing (not an amendment): the raise is fresh.

Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) (https://www.sec.gov/Archives/edgar/data/2151818/000215181826000002/). Last refreshed: 2026-11-04T15:17:01.911Z.
Informational only. SEC EDGAR Form D data is shown for business-development research; it is not investment advice and not an offer or solicitation to buy or sell any security. Not legal or financial advice.